UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: Zeldox20mgmlpulvervatskainjek-SE-PLC-MPD-BBDL

Zeldox 20 mg/ml pulver och vätska till injektionsvätska, lösning

MPID: SE-100023206-00015002
EURDID: 3146

Full name: Zeldox 20 mg/ml pulver och vätska till injektionsvätska, lösning

- Invented name part: Zeldox

- Strength part: 20 mg/ml

- Pharmaceutical dose form part: pulver och vätska till injektionsvätska, lösning

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Powder and solvent for solution for injection

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000097488 ziprasidone

Marketing Authorisation 1 of 1

Authorisation number: 15002

Region: Kingdom of Sweden

Marketing authorisation holder: Upjohn EESV

Identifier:

  • LOC-100032008

Status: Valid (2000-08-17)

Package 1 of 1

PCID:

Description:
Injektionsflaska och ampull, 1 x (I+II)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 1 Ampoule

Package: 1 Box (Cardboard)

Containing:

Package: 1 Vial (Glass type I)

Containing: 1 Vial

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Vial

Ingredient

Role: Active

Substance: Ziprasidone mesilate trihydrate

Presentation strength: 32.7 milligram(s) / 1 Vial

Reference strength:
Ziprasidone 24 milligram(s) / 1 Vial

Ingredient

Role: Excipient

Substance: BETADEX SULFOBUTYL ETHER SODIUM


Package: 1 Ampoule (Glass type I)

Containing: 1 Ampoule

Manufactured Item

Dose form: Solution for solution for injection

Unit of presentation: Ampoule

Ingredient

Role: Excipient

Substance: Water

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Intramuscular use

Ingredients:

Ingredient

Role: Active

Substance: Ziprasidone mesilate trihydrate

Presentation strength: 32.7 milligram(s) / 1 Vial

Reference strength:
Ziprasidone 24 milligram(s) / 1 Vial

Ingredient

Role: Excipient

Substance: BETADEX SULFOBUTYL ETHER SODIUM

Ingredient

Role: Excipient

Substance: Water